Seiichi Hirota

Active 1991–2025

74
Papers
18,805
Citations
57
h-index
73
i10-index

Citations

Citations per year for Seiichi Hirota1978: 1 citations1991: 1 citations1992: 4 citations1993: 8 citations1994: 15 citations1995: 20 citations1996: 33 citations1997: 70 citations1998: 106 citations1999: 234 citations2000: 211 citations2001: 230 citations2002: 300 citations2003: 333 citations2004: 323 citations2005: 316 citations2006: 264 citations2007: 210 citations2008: 215 citations2009: 163 citations2010: 135 citations2011: 146 citations2012: 113 citations2013: 81 citations2014: 88 citations2015: 71 citations2016: 66 citations2017: 65 citations2018: 63 citations2019: 270 citations2020: 265 citations2021: 293 citations2022: 209 citations2023: 129 citations2024: 251 citations2025: 95 citations2026: 1 citations1979–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,924 citing papers, 32.6% of this breakdownJapan: 656 citing papers, 11.1% of this breakdownChina: 413 citing papers, 7% of this breakdownGermany: 339 citing papers, 5.7% of this breakdownUnited Kingdom: 311 citing papers, 5.3% of this breakdownFrance: 223 citing papers, 3.8% of this breakdownItaly: 219 citing papers, 3.7% of this breakdownCanada: 169 citing papers, 2.9% of this breakdownNetherlands: 144 citing papers, 2.4% of this breakdownAustralia: 125 citing papers, 2.1% of this breakdownSpain: 124 citing papers, 2.1% of this breakdownSwitzerland: 123 citing papers, 2.1% of this breakdown
0%32.6%Other 19.2%

Fields

  • Medicine68.3%
  • Biochemistry, Genetics and Molecular Biology17.8%
  • Immunology and Microbiology8%
  • Neuroscience2.9%
  • Engineering1.7%
  • Computer Science0.3%
  • Other1%

Topics

  • Gastrointestinal Tumor Research and Treatment7.1%
  • Chemokine receptors and signaling6.3%
  • Gastrointestinal disorders and treatments3.5%
  • Immunotherapy and Immune Responses3.3%
  • Sarcoma Diagnosis and Treatment2.5%
  • T-cell and B-cell Immunology2.1%
  • Other75.2%

Coauthors

All papers

Open in search
  1. Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors

    Authors: , , , , , , , , , , , , , , - Science 1998 cited by 4,499

  2. Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hiroko Tanaka, Masashi Sanada, Eiji Sugihara, Taka-Aki Sato, Takashi Maruyama, Hiroyuki Miyoshi, Makoto M. Taketo, Jun Oishi, Ryosaku Inagaki, Yutaka Ueda, Shinya Okamoto, Hideaki Okajima, Yoshiharu Sakai, Takaki Sakurai, Hironori Haga, Seiichi Hirota, Hiroki Ikeuchi, Hiroshi Nakase, Hiroyuki Marusawa, Tsutomu Chiba, Osamu Takeuchi, Satoru Miyano, Hiroshi Seno, Seishi Ogawa - Nature 2019 cited by 255

  3. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

    Authors: , , , , , , , , - Nature 1996 cited by 2,356

  4. Identification of a unique subset of tissue-resident memory CD4 + T cells in Crohn’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2022 cited by 77

  5. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

    Authors: , , , , , , , , , , , - Nature 1998 cited by 1,527

  6. Interleukin-1/-33 Signaling Pathways as Therapeutic Targets for Endometriosis

    Authors: , , , , , , - Frontiers in Immunology 2019 cited by 64

  7. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines

    Authors: , , , , - Gastric Cancer 2015 cited by 486

  8. Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Ultrasound in Medicine & Biology 2019 cited by 145

  9. Aortic Iron Overload With Oxidative Stress and Inflammation in Human and Murine Abdominal Aortic Aneurysm

    Authors: , , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2015 cited by 97

  10. Accuracy of OCT, Grayscale IVUS, and Their Combination for the Diagnosis of Coronary TCFA

    Authors: , , , , , , , , , , , - JACC. Cardiovascular imaging 2015 cited by 146

  11. Automated classification of coronary atherosclerotic plaque in optical frequency domain imaging based on deep learning

    Authors: , , , , , , , , , , , , - Atherosclerosis 2021 cited by 28

  12. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version

    Authors: , , , , , , , , , - International Journal of Clinical Oncology 2008 cited by 352

  13. Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor

    Authors: , , , , , , , , , , , , , - Cancer Research and Treatment 2016 cited by 209

  14. Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I

    Authors: , , , , , - Journal of Gastroenterology 2015 cited by 76

  15. TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours

    Authors: , , , , , , , , , , , , , , , , , , , , , , - British Journal of Cancer 2019 cited by 51

  16. Combination of pimitespib (TAS‐116) with sunitinib is an effective therapy for imatinib‐resistant gastrointestinal stromal tumors

    Authors: , , , , , , , , , , , , , , , , , , , - International Journal of Cancer 2023 cited by 24

  17. Targeted therapy for drug-tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours

    Authors: , , , , , , , , , , , , , , , , , - British Journal of Cancer 2021 cited by 35

  18. Association between 18F-FDG uptake and molecular subtype of breast cancer

    Authors: , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2015 cited by 82

  19. Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers

    Authors: , , , , , , , , , , , - Breast Cancer 2019 cited by 33

  20. Biological and clinical review of stromal tumors in the gastrointestinal tract.

    Authors: , - 2000 cited by 313

  21. Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib‐resistant gastrointestinal stromal tumor

    Authors: , , , , , , - Cancer Science 2008 cited by 111

  22. English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , - International Journal of Clinical Oncology 2024 cited by 57

  23. Tumor‐associated macrophage‐derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Science 2020 cited by 24

  24. Postnatal Growth Failure, Short Life Span, and Early Onset of Cellular Senescence and Subsequent Immortalization in Mice Lacking the Xeroderma Pigmentosum Group G Gene

    Authors: , , , , , , , , , , - Molecular and Cellular Biology 1999 cited by 120